Inventor · disambiguated record
Robert Tell
Also filed as: TELL ROBERT · TELL ROBERT W
9 granted patents·14 pending applications·254 citations·filing 1989–2025
89Inventor score
Top patents by PatentIndex Score
23 records- 0194US12112839B2Data based cancer research and treatment systems and methodsTEMPUS AI INC·Filed 2023·Granted Oct 8, 2024·6 cites·20 claims
- 0294US11211144B2Methods and systems for refining copy number variation in a liquid biopsy assayTEMPUS LABS INC·Filed 2021·Granted Dec 28, 2021·6 cites·100 claims
- 0393US11211147B2Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencingTEMPUS LABS INC·Filed 2021·Granted Dec 28, 2021·8 cites·81 claims
- 0492US11705226B2Data based cancer research and treatment systems and methodsTempus Labs·Filed 2019·Granted Jul 18, 2023·24 cites·86 claims
- 0592US11475981B2Methods and systems for dynamic variant thresholding in a liquid biopsy assayTEMPUS LABS INC·Filed 2021·Granted Oct 18, 2022·4 cites·29 claims
- 0690US10975445B2Integrated machine-learning framework to estimate homologous recombination deficiencyTEMPUS LABS INC·Filed 2020·Granted Apr 13, 2021·12 cites·31 claims
- 0790US5173749AMethod and apparatus for spectroscopic measurement of the concentration of a gasALTOPTRONIC AB·Filed 1989·Granted Dec 22, 1992·189 cites·14 claims
- 0883US11640859B2Data based cancer research and treatment systems and methodsTempus Labs·Filed 2019·Granted May 2, 2023·5 cites·83 claims
- 0983US2024312581A1Data based cancer research and treatment systems and methodsTEMPUS AI INC·Filed 2024·Application pending·0 cites
- 1080US2025061972A1Molecular response and progression detection from circulating cell free dnaTEMPUS AI INC·Filed 2024·Application pending·0 cites
- 1172US2025125050A1Systems and methods for molecular residual disease liquid biopsy assayTEMPUS AI INC·Filed 2024·Application pending·0 cites
- 1271US11651442B2Mobile supplementation, extraction, and analysis of health recordsTEMPUS LABS INC·Filed 2022·Granted May 16, 2023·0 cites·30 claims
- 1370US2022336046A1Methods and systems for refining copy number variation in a liquid biopsy assayTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 1470US2022367006A1Methods and systems for dynamic variant thresholding in a liquid biopsy assayTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 1568US2022328133A1Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencingTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 1668US2025137063A1Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencingTEMPUS AI INC·Filed 2024·Application pending·0 cites
- 1766US2021398617A1Molecular response and progression detection from circulating cell free dnaTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 1864US2025279214A1Cancer treatment efficacy evaluation upon undergoing or completing a cancer treatmentTEMPUS AI INC·Filed 2025·Application pending·0 cites
- 1963US2023245788A1Data based cancer research and treatment systems and methodsTEMPUS LABS INC·Filed 2023·Application pending·0 cites
- 2060US2022367010A1Molecular response and progression detection from circulating cell free dnaTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 2152US2023197269A1Systems and methods for detecting viral dna from sequencingTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 2250US2020365232A1Adaptive order fulfillment and tracking methods and systemsTempus Labs·Filed 2020·Application pending·0 cites
- 2336US2016138110A1Glioma biomarkersUNIV NORTHWESTERN·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Tell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →